Exploring Nanoemulsions for Prostate Cancer Therapy

Abstract

Prostate carcinoma is typical cancer. It is the second most common cancer globally. The estimated new cases in 2020 was 191 930 and estimated deaths was 33 330. Age, family history, & genetic factors are major factors that drive prostate cancer. Although, for treating metastatic disease, the major therapies available are radiation,bisphosphonate, and palliative chemotherapy. But the major drawback is therapy is disease-driven and later becomes metastatic and requires treatment. The ability to revolutionize cancer treatment by major targeting vehicles via the exploration of nanoemulsion suggests a potential for cancer treatment. The unique property of a biphasic liquid dosage form called nanoemulsion to reach leaky tumor vasculature is due to its nano-meter oil-droplet size of 20–200 nm. Recent reporting on nanoemulsions disclose their embracing and lay alternative for re-purposing herbal and synthetic drugs and their combination especially for targeting prostate cancer formulating an obtainable nanomedicine. So, this article emphasizes the use of nanoemulsions incorporating therapeutic agents for successful and targeted delivery for prostate cancer.

Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy

“…Nanoemulsions have the advantages of a straightforward preparation procedure, increases in drug solubility, decreases in drug enzymatic dissolution in the body, a protective effect on medications, enhancements drug absorption in the gastrointestinal system, enhancements of drug bioavailability, etc. [137][138][139][140] Bharmoria et al 106 developed a biomaterial that is compatible with CUR and has a suitable structure. The developed biomaterial started by preparing an oil-in-water nanoemulsion using a cytocompatible copolymer (Pluronic F 127) coated with a positively charged protein (gelatin) designed as G-Cur-NE.…”

Upgrading the Transdermal Biomedical Capabilities of Thyme Essential Oil Nanoemulsions Using Amphiphilic Oligochitosan Vehicles

“…In recent years, the use of nanoemulsion-based systems to deliver lipophilic bioactive ingredients such as vaccines, proteins, vitamins, essential oils [ 1 ], preservatives, antimicrobial [ 2 ], anticancer [ 3 ], antiviral, anti-inflammatory, ophthalmic [ 4 ], and Alzheimer’s drugs [ 5 ] has attracted great interest. Embedding bioactive ingredients into the nanoemulsions (NEs) enhances their physicochemical stability, imparts functional potentials, and increases bioavailability as well as transdermal permeability, all of which affect the nanoemulsion’s end-use properties in medicinal and cosmetic applications [ 6 ].…”